Noemi Cardenas Rodriguez | Biochemistry and Molecular Biology | Women Researcher Award

Published on by World Top Scientists

Dr. Noemi Cardenas Rodriguez | Biochemistry and Molecular Biology | Women Researcher Award

 Reserarcher | Instituto Nacional de Pediatría | Mexico

Dr. Noemí Cárdenas Rodríguez is a distinguished researcher in medical sciences with a strong specialization in neuroscience, molecular biology, and biochemical research. Her work has significantly advanced the understanding of neuronal toxicity, oxidative stress, and neuroprotective mechanisms, with applications in both experimental and clinical contexts. She has an impressive record of mentorship, guiding students across undergraduate, master’s, and doctoral programs, and actively participates in national and international scientific evaluation committees. Dr. Cárdenas Rodríguez has contributed extensively to high-impact journals, reflecting her commitment to rigorous, innovative research. Her multidisciplinary expertise bridges basic science with potential clinical applications, making her a prominent figure in translational neuroscience. Her research is recognized globally for its relevance and quality, contributing to scientific knowledge and healthcare advancements. According to Scopus, her research impact is measurable with 2,155 citations, 80 documents, and an h-index of 22.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Integrated approach for biochemical and functional characterization of six clinical variants of glucose-6-phosphate dehydrogenase. International Journal of Molecular Sciences, 2025.

2. Post-COVID condition and neuroinflammation: Possible management with antioxidants. International Journal of Molecular Sciences, 2025.

3. Association of vitamin D supplementation with glutathione peroxidase (GPx) activity, interleukine-6 (IL-6) levels, and anxiety and depression scores in patients with post-COVID-19 condition. International Journal of Molecular Sciences, 2025.

4. Nitazoxanide analogs: Synthesis, in vitro giardicidal activity, and effects on Giardia lamblia metabolic gene expression. International Journal of Molecular Sciences, 2025.

5. Effects of digital neurohabilitation on attention and memory in patients with a diagnosis of pediatric obesity: Case series. Brain Sciences, 2025.

Dr. Bhavna Rani | Biochemistry | Best Researcher Award

Published on by World Top Scientists

Dr. Bhavna Rani | Biochemistry | Best Researcher Award

Researcher at Uppsala university, Sweden

Dr. Bhavna Rani is an accomplished molecular and cell biologist with over a decade of research experience spanning academia and industry across Europe. Her work focuses on cancer biology, stem cells, and cell signaling, employing advanced techniques such as 10X CITE-seq, click chemistry, and high-resolution imaging. She has held postdoctoral positions at prestigious institutions including Uppsala University and the Karolinska Institute, contributing to high-impact research and authoring numerous peer-reviewed publications. Dr. Rani is also actively involved in teaching and mentoring at both master’s and doctoral levels and has received research grants and recognition for her scientific contributions. Her multidisciplinary expertise includes project management, business innovation, and sustainability practices gained through academic-industry collaborations. Fluent in English and proficient in Swedish, she demonstrates strong communication and leadership skills through her roles in scientific committees and postdoctoral associations. Driven by innovation and collaboration, Dr. Rani is committed to advancing biomedical research and its translational applications.

Professional Profile 

ORCID Profile

Education

Dr. Bhavna Rani holds a Marie Curie-funded Ph.D. in Surgical and Experimental Sciences and Cellular Therapies from the University of Bari, Italy, where she conducted translational cancer research focusing on TGF-beta inhibitors in hepatocellular carcinoma. Prior to that, she completed a top-tier Master’s program (M.Sc.) in Oncology from Vrije University, Amsterdam, Netherlands, gaining a solid foundation in cancer biology and experimental therapeutics. She also holds additional certifications in Intellectual Property Law, Research Ethics, Leadership, Sustainability, and Health Policy from prestigious institutions like Uppsala University and Karolinska Institute. These certifications reflect her commitment to continuous learning and her interdisciplinary approach to research. Her diverse educational background across multiple countries has provided her with strong analytical, theoretical, and ethical frameworks, making her well-equipped for advanced scientific research and academic leadership. This comprehensive education forms the backbone of her successful career in molecular biology and translational research.

Professional Experience

Dr. Bhavna Rani has amassed extensive research experience across leading European institutions. She is currently a researcher at Uppsala University, where she works on centrosome clustering and cancer therapeutics. Previously, she was a postdoctoral researcher at the Karolinska Institute, focusing on integrin signaling in stem cells using 10X CITE-seq and advanced 3D culture models. Her career includes multiple postdoctoral roles in Sweden, Italy, Germany, and Spain, covering areas such as MEK therapy resistance in pancreatic cancer and tumor microenvironment imaging using MRI techniques. She has also gained biotech industry experience during her internship at Key2Brain AB, contributing to Alzheimer’s disease models and sustainability protocols. Additionally, she has been involved in scientific advisory roles, market analysis, and mentoring master’s students. Her professional journey highlights her interdisciplinary expertise, international collaborations, and ability to navigate both academic and industrial research environments effectively.

Research Interest

Dr. Bhavna Rani’s research interests lie at the intersection of molecular cell biology, cancer therapeutics, and regenerative medicine. She is particularly focused on understanding the mechanisms of cytokinesis, centrosome clustering, and cell adhesion in both normal and cancerous cells. Her work extends into integrin-mediated signaling, stem cell biology, and the tumor microenvironment, utilizing tools such as 10X CITE-seq, click chemistry, and 3D scaffolds. She is passionate about translating basic cellular mechanisms into therapeutic strategies, especially in targeting cancer stemness, drug resistance, and abnormal cell division. Her interest in translational science is also evident in her past research on liver regeneration and MEK resistance pathways, as well as her involvement in preclinical studies on Alzheimer’s disease. Through a combination of molecular techniques, imaging, and biomaterial sciences, Dr. Rani aims to develop targeted interventions that improve disease outcomes and patient care in oncology and regenerative medicine.

Award and Honor

Dr. Bhavna Rani has received notable recognition throughout her academic and research career. She was a prestigious Marie Curie Fellow during her Ph.D., an award reserved for top-tier researchers in the EU. Her research has been funded by competitive grants such as the A&M Rudberg and Marcus and Amalia Wallenberg Foundation, acknowledging the impact and promise of her scientific contributions. She has served as a reviewer for peer-reviewed journals like Cancer Medicine, further establishing her authority in the biomedical field. Additionally, she has been an active member of scientific societies, including the European Association for the Study of the Liver (EASL) and the European Society for Clinical Investigation (ESCI). She also held leadership roles in postdoctoral associations at Uppsala University and Karolinska Institute. While her list of named awards could expand, her consistent record of grants, fellowships, and leadership roles reflect strong academic recognition.

Conclusion

Dr. Bhavna Rani is a highly accomplished and driven biomedical researcher whose career spans cutting-edge research in cancer biology, stem cells, and regenerative medicine. With a strong academic foundation and wide-ranging professional experience in both academia and industry, she demonstrates a rare blend of scientific excellence, teaching expertise, and interdisciplinary collaboration. Her research has real-world impact, particularly in understanding complex cellular processes like cytokinesis and integrin signaling in disease contexts. She has contributed to multiple peer-reviewed publications and secured competitive funding, affirming the value of her work. Beyond the lab, she actively participates in teaching, mentoring, and scientific communities, showcasing leadership and commitment to the broader research ecosystem. With her deep expertise, innovative thinking, and collaborative mindset, Dr. Rani is exceptionally well-positioned to continue making meaningful contributions to science and society. Her profile makes her a strong candidate for research awards and future leadership roles in biomedical research.

Publications Top Notes

  • Cytokinesis in Suspension: A Distinctive Trait of Mesenchymal Stem Cells

    • Authors: Rani B, Qian H, Johansson S

    • Year: 2025

  • Contribution of Integrin Adhesion to Cytokinetic Abscission and Genomic Integrity

    • Authors: Rani B, Gupta DK, Johansson S, Kamranvar SA

    • Year: 2022

  • Cell Cycle Regulation by Integrin‑Mediated Adhesion

    • Authors: Kamranvar SA, Rani B, Johansson S

    • Year: 2022

  • Platelets as Key Factors in Hepatocellular Carcinoma

    • Authors: Pavlovic N, Rani B, Gerwins P, Heindryckx F

    • Year: 2019

  • Galunisertib Suppresses the Staminal Phenotype in Hepatocellular Carcinoma by Modulating CD44 Expression

    • Authors: Rani B, Malfettone A, Dituri F, et al.

    • Year: 2018

  • Transforming Growth Factor‑β‑Induced Plasticity Causes a Migratory Stemness Phenotype in Hepatocellular Carcinoma

    • Authors: Malfettone A, Soukupova J, Rani B, et al.

    • Year: 2017

  • MicroRNA‑199a‑5p Inhibition Enhances the Liver Repopulation Ability of Human Embryonic Stem Cell‑Derived Hepatic Cells

    • Authors: Möbus S, Yang D, Yuan Q, Lüdtke TH, Rani B, et al.

    • Year: 2014

  • Moving Towards Personalised Therapy in Patients with Hepatocellular Carcinoma: The Role of the Microenvironment

    • Authors: Giannelli G, Rani B, Dituri F, Cao Y, Palasciano G

    • Year: 2014

  • Role of the Tissue Microenvironment as a Therapeutic Target in Hepatocellular Carcinoma

    • Authors: Rani B, Cao Y, Malfettone A, Tomuleasa C, et al.

    • Year: 2014

  • MicroRNA‑221 Overexpression Accelerates Hepatocyte Proliferation During Liver Regeneration

    • Authors: Yuan Q, Loya K, Rani B, Möbus S, et al.

    • Year: 2013

Edio Maldonado | Biochemistry | Best Researcher Award

Published on by World Top Scientists

Dr. Edio Maldonado | Biochemistry | Best Researcher Award

Profesor, Universidad de Chile, Chile

👨‍🔬 Dr. Edio Luis Maldonado Maldonado is an accomplished biochemist and molecular biologist specializing in transcription regulation and molecular biology. Currently, he serves as an Associate Professor at the University of Chile, where he contributes to the Cellular and Molecular Biology Program. With a research background that spans several prestigious institutions, Dr. Maldonado is recognized for his pioneering work in RNA polymerase II transcription factors, with his research widely published in prominent scientific journals.

Publication Profile

Scopus

Education

🎓 Dr. Maldonado’s academic journey began with a Bachelor’s in Sciences from Universidad Austral de Chile (1979-1983). He then pursued a Master’s in Sciences with a focus on Immunology at the same university (1983-1987). To deepen his expertise, he completed his Ph.D. in Biochemistry and Molecular Biology at the University of Medicine and Dentistry of New Jersey (UMDNJ) in the USA (1990-1996).

Experience

🏛️ Dr. Maldonado has held notable academic and research positions throughout his career. He started as an Assistant Professor at the Universidad Austral de Chile (1984-1987). After completing his Ph.D., he undertook postdoctoral research at the Howard Hughes Medical Institute, UMDNJ (1996-1997). He then joined the University of Chile as an Assistant Professor (1997-2004) before advancing to his current role as an Associate Professor at the Faculty of Medicine in the Cellular and Molecular Biology Program.

Research Interests

🔬 Dr. Maldonado’s research primarily revolves around the molecular mechanisms of gene transcription in mammalian cells, focusing on the role of RNA polymerase II and its associated transcription factors. His work sheds light on transcriptional regulation, providing insights that could impact various fields, including genetics and disease pathology.

Awards

🏆 Dr. Maldonado’s contributions to molecular biology and biochemistry have earned him respect in the scientific community, with his research frequently cited by peers and featured in high-impact journals.

Publications

“Factors involved in specific transcription by mammalian RNA polymerase II: RNA polymerase II associating protein 30 is an essential component of transcription factor IIF.”
📖 Journal of Biological Chemistry (1988), 2, pp. 975-990.
[Cited by other researchers]

“Factors involved in specific transcription by mammalian RNA polymerase II: factors IIE and IIF independently interact with RNA polymerase II.”
📖 Journal of Biological Chemistry (1989), 264, pp. 8913-8921.
[Cited by other researchers]

“A TATA-like sequence located downstream of the transcriptional initiation site is required for expression of an RNA polymerase II transcribed gene.”
📖 Genes and Development (1990), 4, pp. 1611-1622.
[Cited by other researchers]

“Factors involved in specific transcription by mammalian RNA polymerase II: role of factors IIA, IID and IIB during formation of a transcription competent complex.”
📖 Molecular and Cell Biology (1990), 10, pp. 6335-6347.
[Cited by other researchers]

“Direct Interaction between adenovirus E1a protein and the TATA-box binding transcription factor IID.”
📖 Proceedings of the National Academy of Sciences USA (1991), 88, pp. 5124-5128.
[Cited by other researchers]

 

Magellan Tchouakui | Biochemistry | Young Scientist Award

Published on by World Top Scientists

 Dr. Magellan Tchouakui | Biochemistry | Young Scientist Award

Research scientist, Centre for Research in Infectious Diseases, Cameroon

🧬 Dr. Magellan Tchouakui is a Cameroonian research scientist at the Centre for Research in Infectious Diseases (CRID) and a Wellcome Trust Early-Career Fellow in Infection and Immunobiology at CRID/Liverpool School of Tropical Medicine (LSTM). Having completed his Ph.D. in 2020, he has authored over 40 peer-reviewed articles focusing on mosquito biology, insecticide resistance, and malaria transmission. His current research is supported by a prestigious Wellcome Trust Early Career Grant, running from 2024 to 2029, aimed at characterizing insecticide resistance-associated fitness costs in major African malaria vectors.

Profile

Google Scholar

Strengths for the Award

  1. Research Excellence and Innovation:
    • Dr. Tchouakui has made significant contributions to the field of medical entomology, particularly in understanding insecticide resistance in malaria vectors.
    • His work on the fitness cost of metabolic resistance to insecticides in African malaria vectors is pioneering and critical for malaria control strategies.
    • With over 40 peer-reviewed articles, he has a robust publication record in high-impact journals, showcasing the quality and impact of his research.
  2. Grants and Funding:
    • He has secured prestigious grants, such as the Wellcome Trust Early-Career Fellowship, demonstrating his ability to attract substantial research funding.
    • His role as PI and Co-PI in multiple projects funded by leading organizations (Wellcome Trust, CDC, Bayer, etc.) indicates strong leadership and project management skills.
  3. Professional Development and Contribution:
    • Dr. Tchouakui has been actively involved in various training programs and workshops, both as a participant and facilitator, indicating his commitment to continuous learning and knowledge dissemination.
    • His involvement in experimental trials for bed nets and indoor residual spraying products highlights his practical contributions to malaria control.
  4. Teaching and Mentorship:
    • He has experience lecturing in biostatistics, bacteriology, and mycology, and has been mentoring Ph.D. and Master’s students, demonstrating his dedication to educating the next generation of scientists.
  5. Recognition and Awards:
    • Numerous travel grants and invitations to present at international conferences underscore his recognition in the scientific community.
    • His role as a reviewer for several prestigious journals signifies his expertise and standing in the field.
  6. Professional Networks:
    • Membership in professional organizations such as ASTMH, PAMCA, and involvement in networks like VectorBiTE and AntiVec reflect his active engagement with the global research community.

Areas for Improvement

  1. Diversity of Research Focus:
    • While Dr. Tchouakui’s research on insecticide resistance is critical, broadening his research focus to include other aspects of vector control or related fields could enhance his contributions and impact.
  2. Collaborative Research:
    • Increasing collaborative efforts with researchers from different fields or regions may provide new insights and foster interdisciplinary approaches to malaria control.
  3. Public Engagement and Outreach:
    • Enhancing public engagement and science communication efforts can help translate research findings into policy and practice more effectively.
    • Participating in community outreach programs to educate the public about malaria prevention and control could amplify the societal impact of his work.
  4. Resource Allocation and Project Management:
    • Ensuring efficient allocation of resources and effective project management to maximize the outcomes of funded projects can further strengthen his research impact.

Education

🎓 Dr. Tchouakui holds a Ph.D. in Parasitology and Ecology from the University of Yaounde I (2020), where his thesis explored the fitness cost of metabolic resistance to insecticides in African malaria vectors. He also earned a Master of Science (MSc) in 2015 and a Bachelor of Science (BSc) in 2012 from the same university.

Experience

🔬 Dr. Tchouakui began his postdoctoral research at CRID under a Bill & Melinda Gates Foundation project, focusing on identifying markers of resistance to novel insecticides. He has extensive experience in mosquito biology, insecticide resistance monitoring, fitness cost evaluation, and malaria transmission studies. Additionally, he has facilitated numerous workshops and training sessions in molecular entomology and vector control.

Research Interest

🔍 Dr. Tchouakui’s research interests include studying the genetic and molecular mechanisms of insecticide resistance in malaria vectors, evaluating the efficacy of vector control tools, and investigating the fitness costs associated with resistance. He employs transcriptomic and genomic approaches to understand the drivers of resistance and collaborates on projects aimed at improving malaria vector management.

Awards

🏆 Dr. Tchouakui has received several travel grants to attend and present at international conferences, including the 3rd International Conference on Public Health in Africa (2023) and the 72nd Annual Meeting of the American Society of Tropical Medicine and Hygiene (2023). He is also a reviewer for multiple scientific journals.

Publications Top Notes

📚 Dr. Tchouakui has published numerous impactful research papers. Here are some of his key publications:

Cytochrome P450 metabolic resistance (CYP6P9a) to pyrethroids imposes a fitness cost in the major African malaria vector Anopheles funestus (Heredity, 2020) – Cited by 621

Combined over-expression of two cytochrome P450 genes exacerbates the fitness cost of pyrethroid resistance in the major African malaria vector Anopheles funestus (Pesticide Biochemistry and Physiology, 2021) – Cited by 632

A 6.5kb Intergenic Structural Variation Exacerbates the Fitness Cost of P450-Based Metabolic Resistance in the Major African Malaria Vector Anopheles funestus (Genes, 2022) – Cited by 626

Fitness Costs of the Glutathione S-Transferase Epsilon 2 (L119F-GSTe2) Mediated Metabolic Resistance to Insecticides in the Major African Malaria Vector Anopheles funestus (Genes, 2018) – Cited by 645

A marker of glutathione S-transferase-mediated resistance to insecticides is associated with higher Plasmodium infection in the African malaria vector Anopheles funestus (Scientific Reports, 2019) – Cited by 5772

Conclusion

Dr. Magellan Tchouakui is a highly accomplished researcher whose work has significantly advanced our understanding of insecticide resistance in malaria vectors. His extensive publication record, successful grant acquisitions, and active participation in professional development activities make him a strong candidate for the Best Researcher Award. While he could benefit from diversifying his research focus and enhancing public engagement, his current contributions and ongoing projects already demonstrate exceptional promise and impact in the field of medical entomology.